BENSON REED L 4
4 · Co-Diagnostics, Inc. · Filed Nov 30, 2020
Insider Transaction Report
Form 4
BENSON REED L
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2020-11-25$1.10/sh−10,476$11,524→ 89,524 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-11-25−100,000→ 25,000 totalExercise: $1.10Exp: 2029-09-02→ Common Stock (100,000 underlying) - Exercise/Conversion
Common Stock
2020-11-25$1.10/sh+100,000$110,000→ 100,000 total - Sale
Common Stock
2020-11-25$10.50/sh−89,524$940,002→ 0 total
Footnotes (3)
- [F1]Non-Qualified Stock Option granted to Reporting Person on September 3, 2019 pursuant to the Issuer's 2015 Long-Term Incentive Plan, as amended, to purchase up to 125,000 shares of common stock of the Issuer and previously reported on a Form 4 filed with the Commission on November 15, 2019.
- [F2]100,000 of the Options have vested.
- [F3]Reflects 10,476 shares withheld by the Issuer at the market price of $10.50 per share less the exercise price of $1.10 per share to fund the cashless exercise of 100,000 options owned by the Reporting Person.